Page last updated: 2024-11-06
direct red 12b
Description
Direct Red 12B, also known as C.I. 28250, is an azo dye. It is used as a dye for leather, paper, and textiles. It is produced by diazotization of 4-amino-2-nitrodiphenylamine and coupling with 2-naphthol-6-sulphonic acid. The dye is typically red in color. Direct Red 12B has been found to be mutagenic in some studies, but its toxicity is relatively low. The dye is studied for its potential applications in various fields such as dyeing, printing, and medicine. It is important to note that Direct Red 12B, like many other dyes, should be handled with caution and appropriate protective measures should be taken.'
Direct Red 12B: Dyes; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 78698 |
| MeSH ID | M0486011 |
Synonyms (15)
| Synonym |
|---|
| direct red 31 |
| disodium 7,7'-iminobis(4-hydroxy-3-(phenylazo)naphthalene-2-sulphonate) |
| direct red 12b |
| c.i. direct red 31 |
| einecs 225-669-8 |
| 5001-72-9 |
| 2-naphthalenesulfonic acid, 7,7'-iminobis(4-hydroxy-3-(2-phenyldiazenyl)-, sodium salt (1:2) |
| c.i. 29100 |
| c.i. direct red 31, disodium salt |
| AKOS000282969 |
| DTXSID10889484 |
| direct red 31, tech. |
| mfcd01846384 |
| disodium;4-hydroxy-7-[(5-hydroxy-6-phenyldiazenyl-7-sulfonatonaphthalen-2-yl)amino]-3-phenyldiazenylnaphthalene-2-sulfonate |
| 7,7'-iminobis[4-hydroxy-3-(phenylazo)-2-naphthalenesulfonic acid disodium salt |
Research
Studies (8)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 20.19
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 20.19 (24.57) | | Research Supply Index | 2.30 (2.92) | | Research Growth Index | 4.86 (4.65) | | Search Engine Demand Index | 15.26 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |